Literature DB >> 16113831

Regulation of platelet guanylyl cyclase by collagen: evidence that Glycoprotein VI mediates platelet nitric oxide synthesis in response to collagen.

Rocio Riba1, Marzieh Sharifi, Richard W Farndale, Khalid M Naseem.   

Abstract

The molecular regulation of nitric oxide synthase (NOS) in blood platelets is an uncharacterised area of platelet biology. We investigated the mechanism of collagen-stimulated NO synthesis in platelets. Our aim was to identify the key collagen receptor and downstream signalling mechanisms linking collagen to NOS activation. Collagen and the GpVI-specific platelet activator collagen-related peptide (CRP-XL) stimulated NO synthesis, as evidenced by increased [(3)H]L-citrulline production, and cyclic GMP (cGMP) formation. After platelet activation by collagen and CRP-XL was normalised, we found no differences in NOS activation or cGMP formation in response to these agonists. Blocking the interaction of collagen with integrin alpha(2)beta(1), a second collagen receptor, failed to affect NOS activation by collagen. These data indicate that collagen-induced NO synthesis is linked to GpVI activation. cGMP formation in response to collagen and CRP-XL required increased intracellular Ca(2+), Src family kinases, phosphatidylinositol 3-kinase (PI3-K) and protein kinase C. By comparison, Gp VI-independent cGMP formation induced by thrombin was Src kinase-dependent, but was independent of PI3-K and PKC. Thus the mechanisms of collagen- and CRP-XL-induced NOS activation were identical, but distinct from that of thrombin. Platelet activation in response to collagen leads to secretion of adenosine diphosphate (ADP) and thromboxane A(2) (TxA(2)). Our results demonstrate that collagen-stimulated cGMP synthesis was enhanced significantly by platelet-derived ADP and TxA(2). These results reveal that collagen stimulates platelet NOS activation through a specific Ca(2+)-dependent GpVI receptor signalling cascade, and demonstrate that collagen-induced cGMP accrual requires the release of secondary platelet agonists.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113831     DOI: 10.1160/TH05-01-0027

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis.

Authors:  Si Zhang; Shenghui Zhang; Liang Hu; Lili Zhai; Ruyi Xue; Jianqin Ye; Leilei Chen; Guanjun Cheng; Jozef Mruk; Satya P Kunapuli; Zhongren Ding
Journal:  Circulation       Date:  2015-02-17       Impact factor: 29.690

2.  Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase.

Authors:  C Tymvios; C Moore; S Jones; A Solomon; D Sanz-Rosa; M Emerson
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

3.  Effects of nitrite and far-red light on coagulation.

Authors:  Nadeem Wajih; Elmira Alipour; Fernando Rigal; Jiqing Zhu; Andreas Perlegas; David L Caudell; Daniel Kim-Shapiro
Journal:  Nitric Oxide       Date:  2020-11-30       Impact factor: 4.427

Review 4.  Role of the Platelets and Nitric Oxide Biotransformation in Ischemic Stroke: A Translative Review from Bench to Bedside.

Authors:  Maciej Bladowski; Jakub Gawrys; Damian Gajecki; Ewa Szahidewicz-Krupska; Anna Sawicz-Bladowska; Adrian Doroszko
Journal:  Oxid Med Cell Longev       Date:  2020-08-28       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.